Skip to main content
SpringerLink
Log in

Bionanoparticles in the Treatment of Glycation-Induced Secondary Complications of Diabetes

  • Chapter
  • First Online:
Nanomaterials and Plant Potential

Abstract

Diabetes has become a major metabolic and endocrinological disorder. All types of diabetes have common features like hyperglycemia and glucotoxicity. Hyperglycemia leads to accumulation of undesired products due to excess amount of glucose present in the body. The carbonyl group of glucose interacts with amino group of nitrogenous compounds like proteins, nucleic acids, and lipids. This interaction leads to generation of deleterious products, commonly known as advanced glycation end products (AGEs). These AGEs have been implicated in many pathophysiological diseases including diabetes. There has been a continuous effort by researchers to look for the technologies for early detection and effective prevention of glycation products. A few artificial and natural inhibitors have been designed to control the formation of AGEs. In recent times nanotechnology has emerged as reliable and sensitive technique for the diagnosis and treatment of secondary complications of diabetes. There are reports which signify the role of plant-mediated nanoparticles as sensors of glucose, glycated proteins, protein oxidation, and AGEs. This chapter deals with the recent advances in the field of glycation and applications of bio-nanotechnology in the detection, prevention, and treatment of glycation-induced secondary complications of diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AGE:

Advanced glycation end products

CML:

Carboxymethyl-lysine

GA:

Glycated albumin

HbA1c:

Glycated hemoglobin

MG:

Methylglyoxal

NP:

Nanoparticle

RAGE:

Receptors for advanced glycation end products

References

  • Abbas G, Al-Harrasi AS, Hussain H, Hussain J, Rashid R, Choudhary MI (2016) Antiglycation therapy: discovery of promising antiglycation agents for the management of diabetic complications. Pharm Biol 54:198–206

    Article  CAS  Google Scholar 

  • Ali A, More TA, Hoonjan AK, Sivakami S (2017) Antiglycating potential of acesulfame potassium: an artificial sweetener. Appl Physiol Nutr Metab 42:1054–1063

    Article  CAS  Google Scholar 

  • Ali A, Sharma R (2015) A comparative study on the role of lysine and BSA in glycation-induced damage to DNA. Biosci Bioeng Commun 1:38–43

    Google Scholar 

  • Ali A, Sharma R, Sivakami S (2014) Role of natural compounds in the prevention of DNA and proteins damage by glycation. Bionano Front 7:25–30

    Google Scholar 

  • Ashraf JM, Ansari MA, Choi I, Khan HM, Alzohairy MA (2014) Antiglycating potential of gum arabic capped-silver nanoparticles. Appl Biochem Biotechnol 174:398–410

    Article  CAS  Google Scholar 

  • Ashraf JM, Ansari MA, Fatma S, Saleh MSA, Iqbal J, Madkhali A, Hamali AH, Ahmad S, Jerah A, Echeverria V, Barreto GE, Ashraf GM (2018) Inhibiting effect of zinc oxide nanoparticles on advanced glycation products and oxidative modifications: a potential tool to counteract oxidative stress in neurodegenerative diseases. Mol Neurobiol 55:7438. https://doi.org/10.1007/s12035-018-0935-x

    Article  CAS  PubMed  Google Scholar 

  • Ashraf JM, Ansari MA, Khan HM, Alzohairy MA, Choi I (2016) Green synthesis of silver nanoparticles and characterization of their inhibitory effects on advanced glycation end products formation using biophysical techniques. Sci Rep 6:20414

    Article  CAS  Google Scholar 

  • Banan P, Ali A (2016) Preventive effect of phenolic acids on in vitro glycation. Ann Phytomed 5:97–102

    Article  CAS  Google Scholar 

  • Bhat BG, Younis H, Herrera J, Palacio K, Pascual B, Hur G, Jessen B, Ogilvie KM, Rejto PA (2008) Antisense inhibition of 11 betahydroxy steroid dehydrogenase type 1 improves diabetes in a novel cortisone-induced diabetic KK mouse model. Biochem Biophys Res Commun 365:740–745

    Google Scholar 

  • Cash KJ, Clark HA (2010) Nanosensors and nanomaterials for monitoring glucose in diabetes. Trends Mol Med 16:584–593

    Article  CAS  Google Scholar 

  • Choi JS, Leong KW, Yoo HS (2008) In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials 29:587–596

    Article  CAS  Google Scholar 

  • Daisy P, Saipriya K (2012) Biochemical analysis of Cassia fistula aqueous extract and phytochemically synthesized gold nanoparticles as hypoglycemic treatment for diabetes mellitus. Int J Nanomedicine 7:1189–1202

    Article  CAS  Google Scholar 

  • Daroux M, Prevost G, Maillard-Lefebvre H, Gaxatte C (2010) Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies. Diabetes Metab 36:1–10

    Article  CAS  Google Scholar 

  • Devarajan PV, Sonavane GS (2007) Preparation and in vitro/in vivo evaluation of gliclazide loaded eudragit nanoparticles as sustained release carriers. Drug Dev Ind Pharm 33:101–111

    Article  CAS  Google Scholar 

  • Ernst E (2005) The efficacy of herbal medicine - an overview. Fundam Clin Pharmacol 19:405–409

    Article  CAS  Google Scholar 

  • Fiuza SM, Gomes C, Teixeira LJ, Girão da Cruz MT, Cordeiro MN, Milhazes N, Borges F, Marques MP (2004) Phenolic acid derivatives with potential anticancer properties-a structure-activity relationship study. Part 1: methyl, propyl and octyl esters of caffeic and gallic acids. Bioorg Med Chem 12:3581–3589

    Article  CAS  Google Scholar 

  • Ghosh S, Datta D, Cheema M, Dutta M, Stroscio MA (2017) Aptasensor based optical detection of glycated albumin for diabetes mellitus diagnosis. Nanotechnology 28:43

    Google Scholar 

  • Ghosh MR, Bhattacharya J, Mitra CK, Basak S, Dasgupta AK (2007) Protein seeding of gold nanoparticles and mechanism of glycation sensing. Nanomedicine 3:208–214

    Article  Google Scholar 

  • Harris CS, Cuerrier A, Lamont E, Haddad PS, Arnason JT, Bennett SA, Johns T (2014). Investigating wild berries as a dietary approach to reducing the formation of advanced glycation endproducts: chemical correlates of in vitro antiglycation activity. Plant Foods Human Nutrition (Dordrecht, Netherlands) 69(1):71–77

    Google Scholar 

  • Hsieh CL, Peng CH, Chyau CC, Lin YC, Wang HE, Peng RY (2007) Low-density lipoprotein, collagen, and thrombin models reveal that Rosemarinus officinalis L. exhibits potent antiglycative effects. J Agric Food Chem 55:2884–2891

    Google Scholar 

  • Husen A (2017) Gold Nanoparticles from plant system: synthesis, characterization and their application. In: Ghorbanpour M, Manika K, Varma A (eds) Nanoscience and plant–soil systems, vol 48. Springer, Cham, pp 455–479

    Google Scholar 

  • Husen A, Siddiqi KS (2014a) Carbon and fullerene nanomaterials in plant system. J Nanobiotechnol 12:16

    Article  Google Scholar 

  • Husen A, Siddiqi KS (2014b) Phytosynthesis of nanoparticles: concept, controversy and application. Nano Res Lett 9:229

    Article  Google Scholar 

  • Husen A, Siddiqi KS (2014c) Plants and microbes assisted selenium nanoparticles: characterization and application. J Nanobiotechnol 12:28

    Article  Google Scholar 

  • Hussain F, Birch DJS, Pickup JC (2005) Glucose sensing based on the intrinsic fluorescence of sol-gel immobilized yeast hexokinase. Anal Biochem 339:137–143

    Article  CAS  Google Scholar 

  • Jacobs CB, Peairs MJ, Venton BJ (2010) Carbon nanotube based electrochemical sensors for biomolecules. Anal Chim Acta 662:105–127

    Article  CAS  Google Scholar 

  • Jang DS, Lee YM, Jeong IH, Kim JS (2010) Constituents of the flowers of Platycodon grandiflorum with inhibitory activity on advanced glycation end products and rat lens aldose reductase in vitro. Arch Pharmacal Res 33(6):875–880

    Google Scholar 

  • Kang KS, Yamabe N, Kim HY, Yokozawa T (2008) Role of maltol in advanced glycation end products and free radicals, in vitro and in vivo studies. J Pharm Pharmacol 60:445–452

    Article  CAS  Google Scholar 

  • Kim J, Hong C, Koo Y, Choi H, Lee K (2012) Anti-glycation effect of gold nanoparticles on collagen. Biol Pharm Bull 35:260–264

    Article  CAS  Google Scholar 

  • Kowluru RA, Kanwar M (2007) Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab 4:8

    Google Scholar 

  • Landis-Piwowar KR, Huo C, Chen D, Milacic V, Shi G, Chan TH, Dou QP (2007) A novel prodrug of the green tea polyphenol -epigallocatechin-3- gallate as a potential anticancer agent. Cancer Res 67:4303–4310

    Article  CAS  Google Scholar 

  • Lin Y-H, Chen CT, Liang HF, Kulkarni AR, Lee PW, Chen CH, Sung HW (2007) Novel nanoparticles for oral insulin delivery via the paracellular pathway. Nanotechnology 18:105102

    Article  Google Scholar 

  • Luevano-Contreras C, Chapman-Novakofski K (2010) Dietary advanced glycation end products and aging. Nutrients 2:1247–1265

    Article  CAS  Google Scholar 

  • Mandel S, Youdim MB (2004) Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic Biol Med 37:304–317

    Google Scholar 

  • Manikanth SB, Kalishwaralal K, Sriram M, Pandian SRK, Hyung-seop Y, Eom SH, Gurunathan S (2010) Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. J Nanobiotechnol 8:77–81

    Google Scholar 

  • Meeprom A, Sompong W, Chan CB, Adisakwattana S (2013) Isoferulic acid, a new anti-glycation agent, inhibits fructose- and glucose-mediated protein glycation in vitro. Molecules 18:6439–6454

    Article  CAS  Google Scholar 

  • Merrell JG, McLaughlin SW, Tie L, Laurencin CT, Chen AF, Nair LS (2009) Curcumin loaded poly (epsilon-Caprolactone) nanofibers: diabetic wound dressing with antioxidant and anti-inflammatory properties. Clin Exp Pharmacol Physiol 36:1149–1156

    Article  CAS  Google Scholar 

  • Modak M, Dixit P, Londhe J, Ghaskadbi S, Paul T (2007) Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 40:163–173

    Article  Google Scholar 

  • Mu Q, Jiang G, Chen L, Zhou H, Fourches D, Tropsha A, Yan B (2014) Chemical basis of interactions between engineered nanoparticles and biological systems. Chem Rev 114:7740–7781

    Article  CAS  Google Scholar 

  • Nass N, Bartling B, Navarrete Santos A, Scheubel RJ, Borgermann J, Silber RE, Simm A (2007) Advanced glycation end products, diabetes and ageing. Z Gerontol Geriatr 40:349–356

    Article  CAS  Google Scholar 

  • Paul J, Borm A, Kreyling W (2004) Toxicological hazards of inhaled nanoparticles -potential implications for drug delivery. J Nanosci Nanotechnol 4:1–11

    Article  Google Scholar 

  • Perumal V, Manickama T, Bang KS, Velmurugane P, Oh BT (2016) Antidiabetic potential of bioactive molecules coated chitosan nanoparticles in experimental rats. Int J Biol Macromol 92:63–69

    Article  CAS  Google Scholar 

  • Pickup JC, Zhi ZL, Khan F, Saxl T, Birch DJ (2008) Nanomedicine and its potential in diabetes research and practice. Diabetes Metab Res Rev 24:604–610

    Article  CAS  Google Scholar 

  • Pun PBL, Murphy MP (2012) Pathological significance of mitochondrial glycation. Inter J Cell Biol 843505:13

    Google Scholar 

  • Rahisuddin A (2018) Metal nanoparticles as glucose sensor. In: Khan Z (ed) Nanomaterials and their applications. Advanced structured materials, vol 84. Springer, Singapore, pp 143–168

    Chapter  Google Scholar 

  • Rajaram K, Aiswarya DC, Sureshkumar P (2015) Green synthesis of silver nanoparticle using Tephrosia tinctoria and its antidiabetic activity. Mater Lett 138:251–254

    Article  CAS  Google Scholar 

  • Scherer SS, Pietramaggiori G, Matthews J, Perry S, Assmann A, Carothers A, Demcheva M, Muise-Helmericks RC, Seth A, Vournakis JN, Valeri RC, Fischer TH, Hechtman HB, Orgill DP (2009) Poly-N-acetyl glucosamine nanofibers: a new bioactive material to enhance diabetic wound healing by cell migration and angiogenesis. Ann Surg 250:322–330

    Article  Google Scholar 

  • Sengottaiyan A, Aravinthan A, Sudhakar C, Selvam K, Srinivasan P, Govarthanan M, Manoharan K, Selvankumar T (2016) Synthesis and characterization of Solanum nigrum-mediated silver nanoparticles and its protective effect on alloxan-induced diabetic rats. J Nanostruct Chem 6:41–48

    Article  CAS  Google Scholar 

  • Shaw JE, Sicree RA, Zimmet PZ (2010) Diabetes atlas global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87:4–14

    Article  CAS  Google Scholar 

  • Siddiqi KS, Husen A (2016) Engineered gold nanoparticles and plant adaptation potential. Nano Res Lett 11:400

    Article  Google Scholar 

  • Siddiqi KS, Husen A (2017) Plant response to engineered metal oxide nanoparticles. Nanoscale Res Lett 12:92

    Article  Google Scholar 

  • Siddiqi KS, Husen A, Rao RAK (2018a) A review on biosynthesis of silver nanoparticles and their biocidal properties. J Nanobiotechnol 16:14

    Article  Google Scholar 

  • Siddiqi KS, Rahman A, Tajuddin, Husen A (2018b) Properties of zinc oxide nanoparticles and their activity against microbes. Nano Res Lett 13:141

    Article  Google Scholar 

  • Singh R, Kishore L, Kaur N (2014) Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol Res 80:21–35

    Article  CAS  Google Scholar 

  • Smit AJ, Lutgers HL (2004) The clinical relevance of advanced glycation end products (AGE) and recent developments in pharmaceutics to reduce advanced glycation end products accumulation. Curr Med Chem 11:2767–2784

    Article  CAS  Google Scholar 

  • Soumyanath A (2006) Traditional medicines in modern times-anti-diabetic plants. CRC Press, Boca Raton/ London/ New York

    Google Scholar 

  • Suji G, Sivakami S (2003) Approaches to the treatment of diabetes mellitus: an overview. Cell Mol Biol 49:635–639

    CAS  PubMed  Google Scholar 

  • Suji G, Sivakami S (2004) Glucose, glycation and aging. Biogerontology 5:365–373

    Article  CAS  Google Scholar 

  • Swarnalatha L, Rachel C, Ranjan S, Baradwaj P (2012) Evaluation of in-vitro antidiabetic activity of Sphaeranthus amaranthoides mediated silver nanoparticles. Int J Nanomater Biostruct 2:25–29

    Google Scholar 

  • Thorpe SR, Baynes JW (1996) Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging 9:69–77

    Article  CAS  Google Scholar 

  • Thorpe SR, Baynes JW (2003) Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids 25:275–281

    Article  CAS  Google Scholar 

  • Torres-Piedra M, Ortiz-Andrade R, Villalobos-Molina R, Singh N, Medina-Franco JL, Webster SP, Binnie M, Navarrete-Vázquez G, Estrada-Soto S (2010) A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition. Eur J Med Chem 45:2606–2612

    Article  CAS  Google Scholar 

  • Tupe RS, Kemse NG, Khaire AA, Shaikh SA (2016) Attenuation of glycation-induced multiple protein modifications by Indian antidiabetic plant extract. Pharm Biol 55:68–75

    Article  Google Scholar 

  • Vinson JA, Proch J, Bose P, Muchler S, Taffera P, Shuta D, Samman N, Agbor GA (2006) Chocolate is a powerful ex vivo and in vivo antioxidant, an antiatherosclerotic agent in an animal model, and a significant contributor to antioxidants in the European and American Diets. J Agric Food Chem 54:8071–8076

    Google Scholar 

  • Xu H, Aylott JW, Kopelman R (2002) Fluorescent nano-PEBBLE sensors designed for intracellular glucose imaging. Analyst 127:1471–1477

    Article  CAS  Google Scholar 

  • Yu S, Zhang W, Liu W, Zhu W, Guo R, Wang Y, Zhang D, Wang J (2015) The inhibitory effect of selenium nanoparticles on protein glycation in vitro. Nanotechnology 10(26):145703

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Amity Institute of Biotechnology, Amity University, Navi Mumbai, Maharashtra, India

    Pamela Jha

  2. Department of Life Sciences, University of Mumbai, Mumbai, Maharashtra, India

    Ahmad Ali

Authors
  1. Pamela Jha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmad Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Biology, College of Natural and Computational Sciences, University of Gondar, Gondar, Ethiopia

    Azamal Husen

  2. Department of Botany, Faculty of Science, Jamia Hamdard (Deemed University), New Delhi, India

    Muhammad Iqbal

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jha, P., Ali, A. (2019). Bionanoparticles in the Treatment of Glycation-Induced Secondary Complications of Diabetes. In: Husen, A., Iqbal, M. (eds) Nanomaterials and Plant Potential. Springer, Cham. https://doi.org/10.1007/978-3-030-05569-1_12

Download citation

Publish with us

Policies and ethics

Search

Navigation